These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31014670)

  • 1. Long noncoding RNA CDKN2B-AS1 interacts with miR-411-3p to regulate ovarian cancer in vitro and in vivo through HIF-1a/VEGF/P38 pathway.
    Wang Y; Huang Y; Liu H; Su D; Luo F; Zhou F
    Biochem Biophys Res Commun; 2019 Jun; 514(1):44-50. PubMed ID: 31014670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis.
    Xu C; Zhai J; Fu Y
    Neoplasma; 2020 Jul; 67(4):782-793. PubMed ID: 32305052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference of the long noncoding RNA CDKN2B-AS1 upregulates miR-181a-5p/TGFβI axis to restrain the metastasis and promote apoptosis and senescence of cervical cancer cells.
    Zhu L; Zhang Q; Li S; Jiang S; Cui J; Dang G
    Cancer Med; 2019 Apr; 8(4):1721-1730. PubMed ID: 30884187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis.
    Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of ZNF252P-AS1 alleviates ovarian cancer progression by binding miR-324-3p to downregulate LY6K.
    Geng L; Wang Z; Tian Y
    J Ovarian Res; 2022 Jan; 15(1):1. PubMed ID: 34980214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma.
    Dasgupta P; Kulkarni P; Majid S; Hashimoto Y; Shiina M; Shahryari V; Bhat NS; Tabatabai L; Yamamura S; Saini S; Tanaka Y; Dahiya R
    Cell Death Dis; 2020 Aug; 11(8):660. PubMed ID: 32814766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA PSMA3-AS1 promotes cell proliferation, migration, and invasion in ovarian cancer by activating the PI3K/Akt pathway via the miR-378a-3p/GALNT3 axis.
    Xu Z; Jin H; Duan X; Liu H; Zhao X; Fan S; Wang Y; Yao T
    Environ Toxicol; 2021 Dec; 36(12):2562-2577. PubMed ID: 34520102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis.
    Li M; Ning J; Li Z; Fei Q; Zhao C; Ge Y; Wang L
    Biomed Pharmacother; 2019 Oct; 118():109259. PubMed ID: 31369989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA CDKN2B-AS1 contributes to glioma development by regulating the miR-199a-5p/DDR1 axis.
    Lu J; Chen Y; Wen L; Zhou Q; Yan S
    J Gene Med; 2022 Jan; 24(1):e3389. PubMed ID: 34559933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA RHPN1-AS1 promoted cell proliferation, invasion and migration in cervical cancer via the modulation of miR-299-3p/FGF2 axis.
    Duan H; Li X; Chen Y; Wang Y; Li Z
    Life Sci; 2019 Dec; 239():116856. PubMed ID: 31525429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA CDKN2B-AS1 promotes osteosarcoma by increasing the expression of MAP3K3 via sponging miR-4458.
    Gui D; Cao H
    In Vitro Cell Dev Biol Anim; 2020 Jan; 56(1):24-33. PubMed ID: 31950433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA BBOX1-AS1 Aggravates the Development of Ovarian Cancer by Sequestering miR-361-3p to Augment PODXL Expression.
    Yao H; Chen R; Yang Y; Jiang J
    Reprod Sci; 2021 Mar; 28(3):736-744. PubMed ID: 33159291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y; Dun Y; Zhou S; Huang XH
    Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA ILF3-AS1 regulates myocardial infarction via the miR-212-3p/SIRT1 axis and PI3K/Akt signaling pathway.
    Zhang JY; Yang Z; Fang K; Shi ZL; Ren DH; Sun J
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2647-2658. PubMed ID: 32196615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
    Li H; Zhou Y; Cheng H; Tian J; Yang S
    Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299-3p/VEGF axis in vitro and in vivo.
    Li Y; Zheng D; Pan L; Dai Y; Cai S; Zhao L; Zhu H
    Eur J Pharmacol; 2019 Oct; 860():172536. PubMed ID: 31310753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
    Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling
    Dai T; Liang J; Liu W; Zou Y; Niu F; Li M; Zhang H; Li C; Fan M; Cui G
    Bioengineered; 2021 Dec; 12(2):10771-10781. PubMed ID: 34793263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-associated silencing of
    Chen K; Liu MX; Mak CS; Yung MM; Leung TH; Xu D; Ngu SF; Chan KK; Yang H; Ngan HY; Chan DW
    Theranostics; 2018; 8(2):423-436. PubMed ID: 29290818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PITPNA-AS1 Inhibits Cell Proliferation and Migration in Ovarian Cancer by Regulating the MIR-223-3p/RHOB Axis.
    Zhang F; Zhang M; Chen Z; Yu B; He X; Luo Y; Ai F; Hu W
    Rev Invest Clin; 2024 May; 76(2):103-115. PubMed ID: 38753591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.